233 related articles for article (PubMed ID: 29885587)
1. Platinum(IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy.
Guo D; Xu S; Huang Y; Jiang H; Yasen W; Wang N; Su Y; Qian J; Li J; Zhang C; Zhu X
Biomaterials; 2018 Sep; 177():67-77. PubMed ID: 29885587
[TBL] [Abstract][Full Text] [Related]
2. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
3. Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor.
Xu S; Zhu X; Zhang C; Huang W; Zhou Y; Yan D
Nat Commun; 2018 May; 9(1):2053. PubMed ID: 29795534
[TBL] [Abstract][Full Text] [Related]
4. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
5. Photoactivated polyprodrug nanoparticles for effective light-controlled Pt(iv) and siRNA codelivery to achieve synergistic cancer therapy.
Zhang Q; Kuang G; Zhou D; Qi Y; Wang M; Li X; Huang Y
J Mater Chem B; 2020 Jul; 8(27):5903-5911. PubMed ID: 32538396
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-depleting polyprodrug nanoparticle for enhanced photodynamic therapy and cascaded locoregional chemotherapy.
Zhang X; Zhang X; Chen S; Liu Y; Cao C; Cheng G; Wang S
J Colloid Interface Sci; 2024 Sep; 670():279-287. PubMed ID: 38763024
[TBL] [Abstract][Full Text] [Related]
7. Shuttle-Shape Carrier-Free Platinum-Coordinated Nanoreactors with O
Fu X; Yin W; Shi D; Yang Y; He S; Hai J; Hou Z; Fan Z; Zhang D
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32690-32702. PubMed ID: 34229434
[TBL] [Abstract][Full Text] [Related]
8. Anticancer platinum (IV) prodrugs with novel modes of activity.
Chin CF; Wong DY; Jothibasu R; Ang WH
Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869
[TBL] [Abstract][Full Text] [Related]
9. Amplifying Free Radical Generation of AIE Photosensitizer with Small Singlet-Triplet Splitting for Hypoxia-Overcoming Photodynamic Therapy.
Xiao YF; Chen WC; Chen JX; Lu G; Tian S; Cui X; Zhang Z; Chen H; Wan Y; Li S; Lee CS
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5112-5121. PubMed ID: 35048696
[TBL] [Abstract][Full Text] [Related]
10. Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy.
Cai X; Luo Y; Song Y; Liu D; Yan H; Li H; Du D; Zhu C; Lin Y
Nanoscale; 2018 Dec; 10(48):22937-22945. PubMed ID: 30500027
[TBL] [Abstract][Full Text] [Related]
11. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
12. Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source.
Yuan Y; Liu J; Liu B
Angew Chem Int Ed Engl; 2014 Jul; 53(28):7163-8. PubMed ID: 24861823
[TBL] [Abstract][Full Text] [Related]
13. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy.
Guo D; Xu S; Wang N; Jiang H; Huang Y; Jin X; Xue B; Zhang C; Zhu X
Biomaterials; 2017 Nov; 144():188-198. PubMed ID: 28837960
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy.
Zhou Q; Mohammed F; Wang Y; Wang J; Lu N; Li J; Ge Z
J Control Release; 2021 Nov; 339():130-142. PubMed ID: 34560158
[TBL] [Abstract][Full Text] [Related]
15. A Dual Killing Strategy: Photocatalytic Generation of Singlet Oxygen with Concomitant Pt
Norman DJ; Gambardella A; Mount AR; Murray AF; Bradley M
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14189-14192. PubMed ID: 31397963
[TBL] [Abstract][Full Text] [Related]
16. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
Li L; Huang X; Huang R; Gou S; Wang Z; Wang H
Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977
[TBL] [Abstract][Full Text] [Related]
17. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
[TBL] [Abstract][Full Text] [Related]
18. Scintillator-Based Nanohybrids with Sacrificial Electron Prodrug for Enhanced X-ray-Induced Photodynamic Therapy.
Wang H; Lv B; Tang Z; Zhang M; Ge W; Liu Y; He X; Zhao K; Zheng X; He M; Bu W
Nano Lett; 2018 Sep; 18(9):5768-5774. PubMed ID: 30052464
[TBL] [Abstract][Full Text] [Related]
19. A multifunctional platinum(IV) and cyanine dye-based polyprodrug for trimodal imaging-guided chemo-phototherapy.
Li S; Wu Y; Liu S; Wu T; Liu G; Li T; Chen Z
J Mater Chem B; 2022 Feb; 10(7):1031-1041. PubMed ID: 35080231
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
